| 1 |
Which of the following best describes the concept of "beat perception" as it relates to the auditory capabilities of newborn infants?
|
The extraction of a consistent rhythm from a sequence of sounds. |
|
I think that beat perception can refer to the act of detecting the rhythm of pulse from a sound in human (especially infants) which can be from the sound of it (auditory capabilities).
|
I searched up a research on beat perception on children and found a research from PNAS (Wrinkler et al.) that concludes "newborn infants can perceive the beat in music." They used EEG to show that newborns are sensitive to periodic rhythmic patterns and can extract the beat from complex auditory sequences.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
According to the research, what experimental method is used to differentiate beat perception from statistical learning in newborns?
|
Monitoring brain activity using EEG during auditory stimulation. |
|
As said in the previous question, I have found a research that uses EEG to determine that a newborn can have beat perception from detecting auditory sequences. I think this technique apply to this question since they are also trying to detect beat perception.
|
The study from previous question (Wrinkler et al.) uses EEG to monitor brain activity and determine beat perception.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
What does the mismatch response (MMR) in EEG studies indicate about newborns' auditory processing?
|
Sensitivity to regularity violations in sound sequences. |
|
I think that mismatch response can be caused by the brain’s automatic reaction when an expected pattern is violated. For example, if a sound breaks the rhythmic or statistical regularity, the infant’s brain produces an MMR.
|
Wrinkler et al. shows that MMR indicates sensitivity to violations in rhythmic or structural regularity.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
What does the term "statistical learning" refer to in the context of auditory processing in newborns?
|
Extraction of regularities from the order of sounds without explicit feedback. |
|
I think that statistical learning can refer to the ability to detect patterns such as sounds frequently following each other. The brain of infant can automatically deal with transitional probabilities and regularities in sound sequences.
|
Saffran et al. Shows that infants extract statistical patterns from continuous streams of sound. This concept extended and applied in newborn auditory processing research.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
Which condition in the EEG study did NOT result in a differentiation between beat and offbeat responses in newborns?
|
Jittered condition. |
|
Jittered condition shows a completely random timing of sounds with no stable beats. Therefore, newborns will show no differentiation between beat and off-beat responses.
|
I used to fact that "newborn infants can perceive the beat in music" and the logic stated above to figure out the answer.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
Which neural mechanism is thought to underlie the synchronization of movement to a beat?
|
Neural entrainment. |
|
Synchronisation of movement to a beat is supported by neural entrainment, where brain oscillations align their timing with the structure of auditory rhythms.
|
One research by Edward W Large explains how rhythmic perception and movement synchronisation come from entrainment of neural oscillations to external beats.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
How does beat perception in newborns relate to their later musical abilities?
|
It is fundamental for developing rhythmic coordination and timing. |
|
Beat perception is an early developed auditory skills in an infant. Detecting a steady pulse allows infants to later coordinate movement and follow rhythms when playing instruments or singing.
|
Corrigall et al. 2010, highlights that early beat perception supports later rhythmic coordination and timing skills in childhood.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What is the primary purpose of using EEG in studies of auditory processing in newborns?
|
To record brain responses to sounds. |
|
EEG can be used to safely record brain response when giving a stimulus, which is suitable for newborns.
|
EEG uses electrodes to detect electrical activity in each region of the brain. Winkler used it to record infant's brain response to sound in his research.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
What does an isochronous condition in an auditory study typically involve?
|
A consistent temporal interval between sounds. |
|
Isochronous condition is when a sound is consistent, having the same time between each beat.
|
Wrinkler et al, 2009 uses isochronous sequence to examine beat perception by maintaining fixed inter-tone intervals.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
Which auditory feature is NOT directly studied in the newborn auditory processing research?
|
Language comprehension. |
|
The auditory processing research aims on detecting how newborn perceive audio patterns, not language.
|
Most of the researches I found about newborn auditory processing only examines rhythm and pattern processing, not comprehension of language.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What term is used to describe the appearance of scientific credibility used in the marketing of unproven cell-based therapies?
|
Tokens of scientific legitimacy |
|
I think that the term "tokens of scientific legitimacy" can refer to superficial signs that make an unproven cell-based therapy appear scientific, even when it lacks real evidence.
|
Turner (2012) and Sipp et al. (2017) describe how clinics offering unproven stem-cell therapies rely on tokens of scientific legitimacy to create a scientific proves that hides the lack of evidence.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
According to the article, which of the following is NOT a recognized reporting mechanism for adverse effects from cell and gene therapies?
|
Consumer Protection Agencies |
|
Consumer Protection Agencies is not in the article as a reporting mechanism for the effects from cell and gene therapies.
|
I looked through the paper and found that Consumer Protection Agencies is not mentioned.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What ethical consideration is primarily challenged by direct-to-consumer marketing of unproven cell and gene therapies?
|
Informed consent processes |
|
Marketing directly to consumer about unproven cell and gene therapies does not follow informed consent, because patients are exposed to misleading claims and “tokens of scientific legitimacy.”
|
The paper shows that “Key considerations to support evidence-based cell and gene therapies and oppose marketing of unproven products.” Highlighting that misleading advertising does not follow ethical informed consent
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What key feature differentiates proven CGT products from unproven ones according to regulatory standards?
|
Pre-marketing authorization by regulatory bodies |
|
Autorization by regulatory bodies is the only choice that creates proven cell and gene therapy.
|
The paper states that regulatory authorization is the essential dividing line between validated therapies and unproven ones.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
Which of the following is a risk associated with unproven CGT products highlighted in the article?
|
Potential for serious health risks |
|
Since unproven CGT are not tested in controlled clinical trials and lack proper manufacturing standards, they can contain unseen health risks.
|
The paper warns that unproven CGT interventions have substantial health dangers due to lack of pre-clinical evidence
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
Which of the following is NOT a typical characteristic of unproven CGT products as discussed in the article?
|
Approval by major regulatory agencies |
|
The choice is right because approval by major agencies is a major hallmark of proven, evidence-based therapies.
|
The paper explains that unproven therapies bypass authorization, making regulatory approval fundamentally incompatible with this category.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
How do regulatory bodies like the FDA and EMA ensure the safety of CGT products?
|
By requiring rigorous pre-marketing clinical trials |
|
Regulators do not run their own trials, approve ads, or allow marketing of unverified CGTs.
|
The paper highlights that rigorous pre-marketing evaluation is the most important factor separating proven therapies from unproven ones.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What is the primary goal of the ISCT's position on cell and gene therapies as mentioned in the article?
|
To support evidence-based products and oppose unproven ones |
|
The ISCT highlights this goal multiple times throughout the paper
|
The paper clearly states its purpose: "strengthening evidence-based practice and combating the global spread of unproven CGT products."
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
What is a potential consequence for patients using unproven CGT products?
|
Risk of serious adverse effects |
|
Like stated before, unproven CGT can contain many risks due to lack of approved tests.
|
The paper suggests that serious adverse effects are a primary danger of these unproven CGTs.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
What role does the ISCT play in the context of cell and gene therapies?
|
It opposes the premature commercialization of unproven therapies. |
|
It is the only choice that correctly describes ISCT.
|
The paper explains that ISCT’s key role is supporting evidence-based CGTs and opposing premature, unsafe commercialisation.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|